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Background: Hypercholesterolemia is one of the major modifiable risk factors for athero-
sclerosis of the coronary and carotid arteries. Although transcranial Doppler (TCD) studies of 
the cerebral arteries are indicative of decreased cerebral blood flow velocities in patients with 
hypercholesterolemia, the number of these studies has been limited. The aim of this study was 
to assess the hemodynamic status of the cerebral arteries in patients with hypercholesterolemia 
using TCD.
Methods: In a case-control study, 60 individuals, including 30 hypercholesterolemic cases 
(low-density lipoprotein [LDL] . 160 mg/dL) and 30 healthy controls were enrolled. Other 
arterial risk factors, including diabetes mellitus, hypertension, smoking, and obesity (body mass 
index . 30), were evaluated and matched as well. TCD was used to assess the hemodynamics 
of the intracranial arteries as well as the internal carotid arteries. The mean blood flow velocity, 
pulsatility index, and resistance index were recorded in all the arteries.
Results: The mean blood flow velocity, pulsatility index, and resistance index of the intracranial 
arteries and internal carotid arteries were not significantly different between the two groups 
(P . 0.05). However, those with higher levels of LDL (.180 mg/dL) showed significantly 
lower mean blood flow velocity and resistance index of the internal carotid arteries than the 
healthy controls. In addition, individuals with high-density lipoprotein (HDL) ,35 mg/dL had 
significantly lower mean blood flow velocity in the internal carotid arteries.
Conclusion: Hypercholesterolemia (LDL . 160 mg/dL) does not seem to have a detrimental 
effect on the hemodynamic status of the intracranial arteries and internal carotid arteries. How-
ever, in cases of higher LDL (.180 mg/dL) and lower HDL, decreased TCD parameters in the 
internal carotid arteries, as a surrogate of the peripheral arteries, are prominent.
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Introduction
Cerebrovascular disease and subsequent stroke is one of the most important neurologi-
cal diseases. Several modifiable (eg, hypertension, hyperlipidemia, obesity, smoking, 
and diabetes) and nonmodifiable (eg, gender, age, and race) risk factors for stroke have 
been established.1 Hypercholesterolemia is one of the major modifiable risk factors for 
atherosclerosis of the coronary and carotid arteries. However, its role in the pathogen-
esis of stroke is unknown.2–4 Although early epidemiological studies failed to find an 
association between cholesterol levels and overall stroke risk,5,6 later investigations 
revealed a relationship between dyslipidemia and risk of ischemic stroke.7–9
Assessments of human and animal arterial vasculature revealed an impaired 
endothelial function in hypercholesterolemia.10–12 In addition, transcranial Doppler Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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(TCD) studies of the major cerebral arteries have shown 
decreased cerebral blood flow velocities in patients with 
familial hypercholesterolemia.13 Nonetheless, studies of the 
hemodynamics of the cerebral vasculature in hypercholes-
terolemic patients are limited. The present study aimed at 
assessing the hemodynamic status of the cerebral arteries in 
patients with hypercholesterolemia using TCD.
Methods
In this case-control study, 60 individuals comprising 
30 hypercholesterolemic cases (low-density lipoprotein 
[LDL] .160 mg/dL) and 30 healthy controls were enrolled in 
a university-affiliated hospital in Tabriz, Iran. The study was 
approved by the local ethics committee and written informed 
consent was obtained for each subject. Both groups were 
age- and gender-matched. Other arterial risk factors includ-
ing diabetes mellitus, hypertension, smoking, and obesity 
(body mass index . 30) were evaluated and matched as 
well. Individuals who had given up smoking for more than 
five years were considered to be nonsmokers. TCD was used 
to assess the hemodynamics of the cerebral arteries (DWL®, 
Multi-Dop®, Germany). The standard method of using a 
2 mHz probe for the intracranial arteries and a 4 mHz probe 
for the cervical carotids was applied in the present study. The 
Doppler signals were detected through the temporal window 
for the middle cerebral artery, anterior cerebral artery and 
two segments of the posterior cranial artery (PCA1, PCA2), 
through the suboccipital window for the vertebral arteries 
and basilar artery, and through the cervical window for 
the internal carotid arteries.14 Mean blood flow velocity, 
pulsatility index, and resistance index were recorded in all 
the arteries.15–17
Data were presented as means ± standard deviations. 
Statistical analysis was performed with SPSS for Windows 
version 13.0 (Chicago, IL) and by using the Chi-square 
test, Fisher’s Exact test, and independent-samples t-test 
wherever appropriate. P , 0.05 was considered statistically 
significant.
Results
Sixty individuals were included in the study, ie, 30 in the 
hypercholesterolemic group and 30 in the healthy control 
group. There were no differences in gender, age, and vascular 
risk factors, including hypertension, diabetes mellitus, smok-
ing, and obesity between the groups (Table 1, P . 0.05). 
Moreover, the mean blood flow velocity, pulsatility index, 
and resistance index of the intracranial arteries and internal 
carotid arteries were not significantly different between the 
two groups (Table 2, P . 0.05).
To find out whether higher levels of LDL alter the hemody-
namics of the cerebral arteries, individuals with LDL levels of 
less and more than 180 mg/dL were compared (Table 3). The 
mean blood flow velocity and resistance index of the internal 
carotid arteries in those with LDL . 180 mg/dL was signifi-
cantly lower than that in individuals with LDL , 180 mg/dL 
(P , 0.05, Table 3). In addition, individuals with high-
density lipoprotein (HDL) ,35 mg/dL were compared 
regarding TCD indices in both groups. The analysis revealed 
a significant difference only in mean blood flow velocity of 
the internal carotid arteries.
Discussion
The hemodynamics of the cerebral vasculature in both healthy 
individuals and patients have been of great research interest.18 
Impaired cerebral vasomotor reactivity to L-arginine and/
or CO2 has been reported in patients with recent stroke,19 
severe internal carotid artery stenosis,20 lacunar infarction, 
and high blood pressure.21 Nonetheless, studies of the hemo-
dynamics of the cerebral vasculature in hypercholesterolemic 
patients are limited. The current literature mainly focuses 
on the effect of lipid-lowering methods on hemodynamic 
alterations in the cranial arteries. Sander et al22 and Sterzer 
et al23 reported an improvement in cerebral vasoreactiv-
ity after statin administration. However, the results of 
  PROSPER (Prospective Study of Pravastatin in the Elderly 
at Risk) failed to confirm this finding.24 On the other hand, 
Pfefferkorn et al25 revealed that cholesterol reduction through 
Table 1 Patients’ demographic data and clinical characteristics (mean ± standard deviation)
Hypercholesterolemia 
group (n = 30)
Control group 
(n = 30)
P value
gender (male:female) 14:16 14:16 1.00
Age (years) 54.66 (36–70) 51.60 (30–75) 0.55
Hypertension, n (%) 13 (43.3) 8 (26.6) 0.27
Diabetes mellitus, n (%) 4 (13.3) 5 (16.6) 1.00
smoker, n (%) 11 (36.6) 4 (13.3) 0.07
Obesity, n (%) 8 (26.6) 5 (16.6) 0.53Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
205
Dopplers of cerebral arteries in hypercholesterolemia
velocity in the extracranial arteries, eg, the common carotid 
artery and internal carotid artery. However, this association 
was an inverse one in the intracranial arteries.28 Nevertheless, 
a few studies of patients with familial hypercholesterolemia 
have reported contrasting results in this regard. Rubba et al13 
and Iannuzzi et al26 found an abnormally low cerebral blood 
flow velocity in the middle cerebral artery prior to LDL 
apheresis in patients with familial hypercholesterolemia. A 
later study by Rubba et al29 demonstrated lower diastolic blood 
flow velocities and a higher pulsatility index in the middle 
cerebral artery in familial hypercholesterolemic patients 
compared with control subjects. It seems that higher levels 
of LDL (about 600 mg/dL) in studies of patients with famil-
ial hypercholesterolemia have reported controversial results 
regarding the hemodynamic status of the cranial arteries.
Although the relationship between hypercholester-
olemia and coronary and carotid artery atherosclerosis 
is established, its role in the pathogenesis of stroke is 
unknown. An ultrasound study has shown a direct rela-
tionship between lipid levels and atherosclerosis of the 
carotid artery.1,30 Moreover, formation of reactive oxygen 
Table 2 Transcranial Doppler indices of the intracranial artery 
(mean ± standard deviation)
Artery Index Hypercholesterolemia 
group (n = 30)
Control  
group 
(n = 30)
P value
McA MV 60.5 ± 18.8 56.2 ± 9.2 0.98
Pi 0.82 ± 0.17 0.78 ± 0.15 0.45
Ri 0.53 ± 0.08 0.51 ± 0.05 0.46
AcA MV 46.4 ± 22.3 63.9 ± 10.1 0.86
Pi 0.76 ± 0.35 0.83 ± 0.5 0.70
Ri 0.46 ± 0.19 0.48 ± 0.14 0.45
icA MV 22 ± 17.9 28.7 ± 9.9 0.15
Pi 0.59 ± 0.45 0.83 ± 0.27 0.08
Ri 0.36 ± 0.26 0.51 ± 0.15 0.06
PcA1 MV 38.9 ± 12.4 37 ± 9.6 0.91
Pi 0.08 ± 0.22 0.76 ± 0.2 0.43
Ri 0.5 ± 0.11 0.49 ± 0.1 0.44
PcA2 MV 40.1 ± 13 38.6 ± 11.3 0.51
Pi 0.79 ± 0.21 0.79 ± 0.16 0.51
Ri 0.5 ± 0.11 0.53 ± 0.12 0.75
VA MV 35.2 ± 11.6 32.9 ± 8.9 0.60
Pi 0.82 ± 0.17 0.76 ± 0.13 0.21
Ri 0.52 ± 0.06 0.51 ± 0.08 0.32
BA MV 41.8 ± 13.2 41.2 ± 11.3 0.62
Pi 0.85 ± 0.17 0.76 ± 0.22 0.14
Ri 0.54 ± 0.06 0.49 ± 0.11 0.12
Abbreviations:  McA,  middle  cerebral  artery;  AcA,  anterior  cerebral  artery; 
ICA, internal carotid artery; PCA1, first segment of posterior cranial artery; PCA2, 
second segment of posterior cranial artery; VA, vertebral artery; BA, basilar artery; 
MV, mean blood flow velocity; PI, pulsatility index; RI, resistive index.
Table 3 Transcranial Doppler indices of intracranial arteries in 
LDL . 180 mg/dL versus , 180 mg/dL groups (mean ± standard 
deviation)
Artery Index LDL 
.180 mg/dL
LDL 
,180 mg/dL
P value
McA MV 56.8 ± 12.56 59.1 ± 15.9 0.54
Pi 0.79 ± 0.19 0.81 ± 0.15 0.50
Ri 0.52 ± 0.09 0.52 ± 0.05 0.41
AcA MV 44.5 ± 23.06 60.4 ± 88 0.69
Pi 0.71 ± 0.35 0.84 ± 0.46 0.23
Ri 0.44 ± 0.19 0.49 ± 0.15 0.27
icA MV 19.3 ± 16 28.4 ± 13.4 0.04*
Pi 0.56 ± 0.44 0.79 ± 0.34 0.055
Ri 0.34 ± 0.26 0.48 ± 0.19 0.02*
PcA1 MV 36 ± 13 38.9 ± 10 0.12
Pi 0.74 ± 0.24 0.8 ± 0.2 0.25
Ri 0.48 ± 0.01 0.51 ± 0.1 0.26
PcA2 MV 39.8 ± 15.4 39.1 ± 10.4 0.96
Pi 0.74 ± 0.23 0.82 ± 0.16 0.22
Ri 0.48 ± 0.12 0.54 ± 0.11 0.18
VA MV 34.7 ± 10 33.6 ± 10.6 0.66
Pi 0.78 ± 0.15 0.8 ± 0.15 0.55
Ri 0.51 ± 0.05 0.52 ± 0.08 0.45
BA MV 39.7 ± 9.1 42.30 ± 13.6 0.23
Pi 0.81 ± 0.16 0.81 ± 0.22 0.80
Ri 0.52 ± 0.06 0.51 ± 0.1 0.80
Note: *Statistically significant (P , 0.05).
Abbreviations:  McA,  middle  cerebral  artery;  AcA,  anterior  cerebral  artery; 
ICA, internal carotid artery; PCA1, first segment of posterior cranial artery; PCA2, 
second segment of posterior cranial artery; VA, vertebral artery; BA, basilar artery; 
MV, mean blood flow velocity; PI, pulsatility index; RI, resistive index.
heparin-mediated   extracorporal LDL precipitation resulted in 
an improvement of cerebrovascular CO2 reactivity in patients 
with coronary heart disease and hyperlipidemia. Interestingly, 
Rubba et al13 and Iannuzzi et al26 noted an increasing trend in 
cerebral blood flow velocities after LDL apheresis in patients 
with familial hypercholesterolemia.
The present study showed that the hemodynamic sta-
tus of the cerebral arteries, including the internal carotid 
arteries, was similar in healthy individuals and those with 
LDL . 160 mg/dL. Nonetheless, in cases of a higher choles-
terol level (LDL . 180 mg/dL), decreased mean blood flow 
velocity and resistance index of the internal carotid artery 
were noted, indicating the effect of high LDL levels only on 
the peripheral arteries. Reduced mean blood flow velocity of 
the internal carotid arteries was also seen with lower levels 
of HDL, probably indicative of the protective effect of HDL 
in prophylaxis of arterial damage. Kerenyi et al27 failed to 
find any significant difference between healthy controls 
and hyperlipidemic patients in cerebrovascular reactivity or 
reserve capacity after intravenous administration of acetazo-
lamide. In a study of stroke-free Chinese individuals, hyper-
cholesterolemia was associated with decreased blood flow Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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species has been deemed to play a role in the pathogenesis 
of cerebral vascular dysfunction during hypercholester-
olemia. Reactive oxygen species impair the response to 
acetylcholine, enhance superoxide activity, and lead finally 
to endothelial dysfunction.31
This study has certain limitations. It was a single-
center study with a quite small sample size. A multicenter 
study including a large number of patients may give more 
concrete results. We did not exclude patients with a drug 
history of lipid-lowering agents. Further investigations 
excluding individuals on lipid-lowering agent therapy, 
eg, statins are recommended. Furthermore, other sources 
of potential bias, including anxiety disorders, were not 
controlled for. On the other hand, some advantages of the 
current study might be highlighted. We matched the hyper-
cholesterolemic and control groups with regard to arterial 
risk factors, including diabetes mellitus, hypertension, 
smoking, and obesity. We applied two different definitions 
of hypercholesterolemia (LDL 160 versus 180 mg/dL) to 
achieve further results.
In conclusion, hypercholesterolemia (LDL . 160 mg/dL) 
does not seem to have a detrimental effect on the hemody-
namic status of the intracranial arteries and internal carotid 
arteries. However, in cases of higher cholesterol levels 
(LDL . 180 mg/dL) and lower levels of HDL, decreased 
TCD parameters for the internal carotid arteries, as a sur-
rogate for the peripheral arteries, are prominent.
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